Use of carbamate compound for preventing, alleviating or treating myotonia
US11389429B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2018 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Mar 18, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a use of a carbamate compound represented by chemical formula 1, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof for preventing, alleviating or treating myotonia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.